States reach deal over marketing, safety of generic opioids - WHYY
Kelley Dougherty - United States | Professional Profile | LinkedIn
Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify - BNN Bloomberg
Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada's AJOVY® (fremanezumab), for the preventive treatment of migraine in
Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
Los fabricantes de medicamentos genéricos inflaron los precios hasta un 1000% en EEUU, según una demanda histórica
Teva Canada Charts a New Prescription for Care
Teva resuelve demanda de accionistas por precio de medicamentos genéricos - enFarma
Teva among generic drugmakers hoping to settle US antitrust probe - PMLiVE
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Kelley Dougherty - Head of Corporate Affairs — Teva Pharmaceuticals, North America - Teva Pharmaceuticals | LinkedIn
Teva orchestrated a massive price fixing scheme with generic competitors, states allege
Kelley Dougherty - United States | Professional Profile | LinkedIn
Teva is at centre of drug price fixing case filed by US states - Gulf Times
Kelley Dougherty - United States | Professional Profile | LinkedIn
Teva Announces Appointment of New Global R&D and Chief Medical Officer
Kelley Dougherty on LinkedIn: #tevagives #holidaygiving #tevaproud
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Kelley Dougherty - United States | Professional Profile | LinkedIn
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva recalls US-made drugs following contamination fears - The Boston Globe
